abstract |
Novel substituted 1,5,7-trisubstituted-1,8-naphthyridin-2 (1H) -one compounds; 1,5,7-trisubstituted-1,6-naphthyridin-2 (1H) -one compounds and 1 , 5,7-Trisubstituted-quinolin-2 (1H) -one compounds, their preparation, their use in the treatment of CSBP / p38 kinase mediated diseases, and pharmaceutical compositions useful in such treatment. |